Clinical studies recruiting near Erfurt

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Diagnostische und interventionelle Radiologie, Helios Klinik · Acandis GmbH · NCT05345483 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
NA · CyberKnife Centrum Mitteldeutschland · University Hospital Schleswig-Holstein · NCT06914544 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · HELIOS Klinikum Erfurt · Eli Lilly and Company · NCT06890598 International HIT-MED Registry (I-HIT-MED)
Phase N/A · HELIOS Klinikum-Erfurt · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0396 · Celgene · NCT05519085 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Helios Klinikum Erfurt · Goethe University · NCT02872987 Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NA · HELIOS Klinikum Erfurt · Leipzig Heart Science gGmbH · NCT06672081 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · Private Practice - Dr. Daniel Bestler /ID# 272741 · AbbVie · NCT06712628 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
Phase 2 · Helios Klinikum Erfurt · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07387198 Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Phase N/A · Helios Klinikum Erfurt · Biotronik SE & Co. KG · NCT04075084 Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
Phase 2 · Helios Klinikum Erfurt · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06981325 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · HELIOS Klinikum Erfurt · Eli Lilly and Company · NCT06119581 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Helios Klinikum Erfurt · Daiichi Sankyo · NCT06203210 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · HELIOS Klinikum Erfurt GmbH, Klinik für Kinder- und Jugendme · University Hospital Muenster · NCT04043494 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Frauenarztpraxis Dr. Apel, Dr. Kolpin · Hoffmann-La Roche · NCT05894239 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Helios Klinikum Erfurt GmbH, Klinik für Kinderheilkunde · Martin Schrappe · NCT03643276 Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSC
Phase 3 · Helios Klinikum Erfurt, Klinik für Strahlentherapie · Universität des Saarlandes · NCT07026474 Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Phase N/A · 40 · Pierre Fabre Pharma GmbH · NCT04045691 The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Phase N/A · Helios Klinikum Erfurt · Helios Health Institute GmbH · NCT04844944 Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NA · HELIOS Klinikum Erfurt, Medizinische Klinik III - Kardiologi · Leipzig Heart Science gGmbH · NCT05786131 A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05344469 PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Dat
Phase N/A · Research Site · AstraZeneca · NCT05573893 A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
Phase N/A · Helios Klinikum Erfurt · Hemovent GmbH · NCT04183660 VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Phase 3 · Helios Klinik · Replimune, Inc. · NCT06264180 The Fourth Left Atrial Appendage Occlusion Study
NA · Katholisches Krankenhaus "St. Johann Nepomuk" · Hamilton Health Sciences Corporation · NCT05963698 IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Phase 3 · Helios Klinikum Erfurt - Klinik fuer Hautkrankheiten und All · Immunocore Ltd · NCT06112314 Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
Phase N/A · Helios Hospital Erfurt, Department of gynaecology · Promedon · NCT05042453

Look up another city

Look up another condition